Navigation Links
BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
Date:11/8/2012

discStyle" type="disc">
  • BNX - Opioid Dependence.  BDSI announced a positive outcome of the Company's pivotal pharmacokinetic study for BNX, which is being developed for the treatment of opioid dependence and utilizes the patented BioErodible MucoAdhesive (BEMA) technology to deliver buprenorphine combined with the opioid antagonist naloxone.  The study, BNX-103, was designed to compare the relative bioavailability of buprenorphine and naloxone between BNX and the reference product, Suboxone. 

    In the upcoming months, BDSI will continue to evaluate its strategic options for the commercialization of BNX in the U.S. and rest of world, including internal approaches, partnership or a combination of these.
    • Opioid Dependence Market Developments.  In September, Reckitt Benckiser, the manufacturer of Suboxone sublingual tablets and films, announced that it had notified the FDA that they will voluntarily discontinue the distribution of Suboxone tablets in the U.S.  The decision was reportedly due to accumulating data demonstrating significantly lower rates of accidental pediatric exposure with Suboxone films compared with their tablet formulation due to the child-resistant, unit-dose packaging of the film versus a multi-dose bottle for the tablets.  As for BNX and our FDA approved product ONSOLIS, child-resistant, unit-dose packaging has always been in place.
       
      Assuming ultimate FDA approval, BNX is expected to compete in the opioid dependence market against Suboxone; therefore, the recent steps taken by Reckitt may significantly and favorably alter the dynamics of the market for BNX.  Specifically, we believe this development will cause the market for Suboxone to convert entirely to the film formulation, likely substantially limiting the impact of potential future generic tablets, which are expected to possibly enter the market in the first half of 201
      '/>"/>

    SOURCE BioDelivery Sciences International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
    2. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
    3. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
    4. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
    5. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
    6. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
    7. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
    8. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
    9. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
    10. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
    11. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
    (Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
    (Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
    Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
    (Date:4/18/2014)... to potential new treatments for breaking the cycle of ... or scarring, is a hallmark of the disease, and ... to serious organ damage and, in some cases, death. ... findings made by Swati Bhattacharyya, PhD, research assistant professor ... protein plays in promoting fibrosis. , "Our results ...
    (Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
    (Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
    (Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
    (Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
    Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2
    ... -16 April, is taking full advantage of its Geneva ... of the World Health Organisation (WHO), the World Heart ... the International Olympics Committee (IOC). On Thursday 14 ... (EACPR) will host joint sessions including a session looking ...
    ... With efforts underway to ban lead-based ammunition as a ... evidence that a prime alternative material for bullets ... report, which found that tungsten accumulates in major structures ... journal Chemical Research in Toxicology . Jose ...
    ... FL (April 6, 2011) Numerous studies show that ... cancer. However, animal studies testing the NSAID naproxen or ... formation. Now, researchers at Fox Chase Cancer Center find ... strain of mutant mice that spontaneously develop colon tumors. ...
    ... By Serena Gordon HealthDay Reporter , ... analysis from the Women,s Health Initiative (WHI) study, researchers ... estrogen-only hormone therapy faded rapidly after they ended the ... stopped taking estrogen, the risk of stroke and blood ...
    ... , WEDNESDAY, April 6 (HealthDay News) -- Compared ... to experience bleeding and infections during and after a ... analyzed data from 20,353 women who had a hysterectomy ... menstruation, benign muscle tumors and pain. Women with ...
    ... strawberries may be a way to help people at risk ... a new study by researchers at The Ohio State University ... Richard J. Solove Research Institute (OSUCCC James) and researchers ... during a press briefing at 8 a.m. April 6 at ...
    Cached Medicine News:Health News:International organizations join forces to promote cardiovascular health 2Health News:International organizations join forces to promote cardiovascular health 3Health News:Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 2Health News:Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends 3Health News:Weight Linked to Complications in Some Hysterectomy Patients 2Health News:An international study in China finds strawberries may slow precancerous growth in the esophagus 2Health News:An international study in China finds strawberries may slow precancerous growth in the esophagus 3
    Iso-Electric Determination Kit; contains 1 bottle of 40 nm Naked Gold Iso-Electric Determination Kit to optimize gold conjugation of antibodies...
    Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...
    Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 50 OD...
    Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 12 OD...
    Medicine Products: